Title: Cetus banks on interleukin
Authors: Buderi, R.
Abstract: Reports that Denmark is the first nation to approve interleukin-2, an immunostimulatory drug, developed by the California genetic engineering firm, Cetus. Cetus hopes other European countries will follow Denmark. Patent battle; Plans.
Subjects: CETUS Corp.
Publication: Nature, 1989, Vol 340, Issue 6230, p174
ISSN: 0028-0836
Publication type: Academic Journal
DOI: 10.1038/340174b0

Cetus banks on interleukin

Buderi, R.